Should India relax regulations for biosimilar products?

08 Aug 2023 364 5

Description

Biosimilar products can be potential game-changers in pharmaceuticals. Recently civil society groups urged the govt to revise India’s biosimilar guidelines so that quality drugs become affordable

Download the all-new Business Standard app:
https://bit.ly/App-BS

Join us:
http://www.facebook.com/bsindia
http://twitter.com/bsindia
https://www.instagram.com/business.standard

Comments (0)

About Us
Nishith Desai Associates (NDA) is a research based international law firm with offices in Mumbai, Bangalore, Silicon Valley, Singapore, New Delhi, Munich and New York.
Help page